Mr. Patrick Frankham reports
PIVOT PHARMA SELECTS SHOPIFY TO POWER CANNABIS PRODUCT SALES IN CANADA
Pivot Pharmaceuticals Inc. has signed an agreement with
Shopify Inc., the world's leading multichannel commerce platform, to build an innovative on-line sales channel for the delivery of Pivot's premium biocannabis product portfolio.
As previously disclosed, Pivot has invested significantly in the acquisition and licensing of patented drug delivery technologies, developed differentiated cannabis formulations using pharmaceutical grade CBD (cannabidiol) and THC (tetrahydrocannabinol) isolates as active ingredients, and worked with the company's network of pharma product experts to create the largest catalogue of bioavailable, stable and effective cannabis products. All of Pivot's products will be marketed under "Pivot Naturals" brand, will be manufactured at cGMP accredited facilities in Canada, California and the European Union, and will be distributed direct to consumer in Canada via Shopify.
"Pivot will leverage the full power of Shopify's e-commerce platform to create a state-of-the-art, on-line destination for consumers in Canada seeking our quality bio-cannabis products. Shopify's unique, industry-leading platform solutions will enable Pivot's brands to seamlessly interact with our new customers, allowing us to accelerate other growth aspects of our business," stated Pivot's chief executive officer, Dr. Patrick Frankham.
Loren Padelford, vice-president of Plus at Shopify, added: "We are pleased to execute this agreement with Pivot Pharmaceuticals and look forward to helping bring their premium products to their customers. The Shopify platform will allow Pivot to provide a tailored customer experience that embraces and adjusts to the unique demands of both consumers and regulators, in a safe and secure manner, while adapting to the specific needs of the various jurisdictions in which Pivot operates."
About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals is a science-based consumer packaged goods cannabis company engaged in the development and commercialization of health and wellness products using innovative, patent-protected drug delivery technologies. Upon receipt of a standard processor licence (pending) from Health Canada, Pivot's premium, bioavailable, stable and effective products will be manufactured at its 50,000-square-foot cGMP facility located in Montreal, Que.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.